CYPHERPUNK TECHNOLOGIES INC. Investment Income, Interest
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Investment Income, Interest of $49.00 thousand for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-11.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2017-08-11
- CYPHERPUNK TECHNOLOGIES INC. investment income, interest for the quarter ending 2017-06-30 was $49.00K, a 1125.00% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. investment income, interest for the quarter ending 2017-03-31 was $50.00K.
- CYPHERPUNK TECHNOLOGIES INC. investment income, interest for the quarter ending 2016-06-30 was $4.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month |
|---|---|---|
| 2017-06-30 | $49.00K 10-Q · filed 2017-08-11 | $99.00K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $50.00K 10-Q · filed 2017-05-12 | |
| 2016-06-30 | $4.00K 10-Q · filed 2017-08-11 | $4.00K 10-Q · filed 2017-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |